Evaluation of the incidence and risk factors of neonatal polycythemia

Basit Öğe Kaydı
dc.contributor.authorDeniz, Yusuf
dc.contributor.authorGuven, Sirin
dc.contributor.authorEkmen, Sadrettin
dc.contributor.authorDogan, Erkan
dc.contributor.authorDurak, Umut
dc.date.accessioned2026-04-04T13:30:49Z
dc.date.available2026-04-04T13:30:49Z
dc.date.issued2024
dc.departmentİnönü Üniversitesi
dc.description.abstractAim: We aimed to evaluate the hematocrit levels of neonatal polycythemia patients with time relation and to understand their relationship with the treatment method, so that neonatal polycythemia can be better understood. Material and Methods: We conducted a retrospective study in newborn polisitemi patients with data in NICU over a 1-year-period - year - period (december 2013-december - december 2014). The relationship between the treatment modalities applied to patients hospitalized with the diagnosis of polycythemia and the 1st hour, 12th hour and 24th hour hematocrit levels were examined. Results: This study was carried out on a total of 50 infants hospitalized in our unit with the diagnosis of polycythemia. Partial exchange therapy (PET) therapy was evaluated as fluid therapy and observation therapy groups. 1st hour, 12th hour and 24th hour hematocrit levels were calculated for each of them separately. Discussion: When the relationship between hematocrit values and treatments was examined, it was observed that those who received fluid therapy had lower hospitalization (1 hour) Hct values than those who did not receive fluid therapy. In contrast to partial exchange transfusion, restrictive management has been confronted with several difficulties. It is therefore imperative to conduct more thorough large-scale cohort studies to further understand the reasons for this.
dc.identifier.doi10.4328/ACAM.21938
dc.identifier.endpage530
dc.identifier.issn2667-663X
dc.identifier.issue8
dc.identifier.orcid0000-0003-3684-2421
dc.identifier.startpage526
dc.identifier.urihttps://doi.org/10.4328/ACAM.21938
dc.identifier.urihttps://hdl.handle.net/11616/108382
dc.identifier.volume15
dc.identifier.wosWOS:001284430000002
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherBayrakol Medical Publisher
dc.relation.ispartofAnnals of Clinical and Analytical Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250329
dc.subjectNewborn
dc.subjectPolycythemia
dc.subjectHematocrit
dc.subjectTreatment
dc.titleEvaluation of the incidence and risk factors of neonatal polycythemia
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu